Skip to content

Dortmund, 1st April 2022

Bei Kaja Reifferts Forschung spielen Bakterien wie Escherichia coli (E. coli) eine wichtige Rolle. Die Nachwuchswissenschaftlerin beobachtet unter anderem die Entwicklung der von ihr kultivierten und behandelten Bakterienstämme.
© ISAS

Bacteria such as Escherichia coli (E. coli) play an important role in Kaja Reiffert’s research. The young scientist monitors the development of the bacterial strains she has cultivated and treated.

Kaja Reiffert (24) is a doctoral student in the Bioimaging working group. In her dissertation, she studies the effects of ultra-small silver nanoparticles on the human body. In order to learn more about her work in the lab, the editorial team asked Kaja to finish the following sentences.

  • At ISAS I am working on…

    investigating the influence of ultra-small metallic nanoparticles (1-2 nm small) on eukaryotic and prokaryotic cells. Eurkaryotes are, for example, fungi, animals or plants. Bacteria are prokaryotes.

  • This research question is important because…

    nanoparticles could potentially prevent bacterial infection in connection with implants in the clinic.

  • My theory is…

    that ultra-small silver nanoparticles show an enhanced antimicrobial effect, but also cytotoxic activity. This means there is a chance that they kill bacteria, but damage our cells at the same time. I want to find out whether I can modulate this ‘toxic’ activity through a combination of different metals and thus adjust it to eukaryotic and prokaryotic cells.

  • The equipment I use most in the lab is…

    the confocal microscope for my analysis of fluorescence-marked nanoparticles.

  • My experiments are…

    amongst others, so-called vitality assays, the cultivation of eukaryotic and prokaryotic cells as well as analyses with microscopes and a flow cytometer. I am always planning new experiments.

  • My highlight every day is…

    to be able to look back on a productive and eventful day.

Kaja Reiffert is doing her PhD at the University of Duisburg-Essen. The title of her dissertation is "Ultra-small Mono- and Bi-metallic Nanoparticles as a Possible Prevention Strategy of Implant-associated Infections" (Ultrakleine mono- und bimetallische Nanopartikel als mögliche Präventionsstrategie Implantat-assoziierter Infektionen). Her work contributes to the research project "Synthesis, structure, and biological effects of ultrasmall (1-2 nm) bimetallic silver-platinum nanoparticles". The German Research Association (DFG) funds the project under the number 452179459.

Share

Further articles

Separating Fluorescence Signals Faster and More Precisely with AI

When different fluorescence signals overlap during microscopy, their clear assignment to specific biological structures becomes difficult. To address this common problem, Dr Davide Panzeri is developing AI-based signal separation methods. The biophysicist has been awarded a Marie Skłodowska-Curie Fellowship by the European Union for his promising research project.

Porträt Dr. Davide Panzeri.

Passionate Research, Shaping the Future

How do GRK5 inhibitors work at the cellular level and within the living organism? Biologist Dr Susanne Grund is working with her colleagues at HI-FIVE on a new therapeutic approach for heart failure. In this portrait, she describes what her day-to-day work looks like, balancing research on human stem cells with studies on mice.

ISAS BFF Uploader

What are you doing at ISAS, Theresa?

Why do mice undergo ultrasound examinations of their hearts? What does a typical working day in the lab involve for a technical assistant in the HI-FIVE research project ? And what challenges does the job present? Theresa Pietz provides fascinating insights into her duties, motivations and experiences working with animals.

Study with Heart: A Doctor Bridging Clinic & Laboratory

What is actually happening behind the scenes of a patient trial? Anna Ruzhyna is a clinical research associate who looks after participants with heart failure as part of the HI-FIVE project. She explains how her work helps to develop new therapeutic approaches for the treatment of heart failure.

Laboratory Meets Clinic: Understanding Heart Function with Stem Cells

How can new therapeutic approaches for heart failure be developed more effectively? Stem cell research plays a central role in the HI-FIVE project. In this interview, PD Dr Anna Klinke (Herz- und Diabeteszentrum NRW) talks about her work between the lab and the clinic. She explains how the versatility of stem cells enables heart and vascular cells to be obtained from individual patients' blood and why this is an important step in investigating the specific effects of new active substances.

What are you doing at ISAS, Kevin?

What changes take place in heart muscle cells when a left ventricular assist device is used? ISAS doctoral student Kevin Hau (28) is tackling this question by researching the consequences of heart attacks using various omics analyses.

Kevin Hau is wearing a white coat bearing the ISAS logo. He is standing next to a microscope in a laboratory. In the lower left corner of the image, a computer screen can be seen. Open on the monitor is a microscopic image of reddish tissue.

Copenhagen: Different Molecules, New Perspectives?

Felix Hormann is spending three months conducting research at the University of Copenhagen. In this interview, the ISAS doctoral student discusses the new perspective he has gained on his lipid research and his exciting day-to-day life as a scientist in Denmark.

Felix Hormann is standing at a crossroads. In the background, there is a traffic sign with writing in Danish.

New Perspectives for Heart Failure Therapy

How are new therapeutic approaches being developed to close the gap in the treatment of patients with heart failure? And what knowledge from clinical practice is crucial for this? Prof. Dr Tanja Rudolph provides insights into her daily work as a cardiologist and talks about her role in the translational research project HI-FIVE, and the future of cardiovascular disease therapy.